BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35368120)

  • 1. Magnetic resonance imaging metrics and the predictability of adverse outcomes in on-treatment Asian chronic hepatitis B.
    Hui RW; Chiu KW; Mak LY; Chang HC; Cheung KS; Fung J; Yuen MF; Seto WK
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1139-1147. PubMed ID: 35368120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma.
    Hui RW; Chan AC; Lo G; Lo R; Chan C; Kotewall CN; Mak LY; She WH; Au KP; Ai V; Fung J; Yuen MF; Seto WK
    Hepatol Int; 2022 Apr; 16(2):371-380. PubMed ID: 35347596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.
    Imajo K; Tetlow L; Dennis A; Shumbayawonda E; Mouchti S; Kendall TJ; Fryer E; Yamanaka S; Honda Y; Kessoku T; Ogawa Y; Yoneda M; Saito S; Kelly C; Kelly MD; Banerjee R; Nakajima A
    World J Gastroenterol; 2021 Feb; 27(7):609-623. PubMed ID: 33642832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection.
    Mak LY; Hui RW; Fung J; Liu F; Wong DK; Li B; Cheung KS; Yuen MF; Seto WK
    Hepatol Int; 2021 Aug; 15(4):901-911. PubMed ID: 34152534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
    Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
    Lee SW; Huang DQ; Bettencourt R; Ajmera V; Tincopa M; Noureddin N; Amangurbanova M; Siddiqi H; Madamba E; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Yoneda M; Idilman R; Gumussoy M; Oz DK; Erden A; Loomba R
    Aliment Pharmacol Ther; 2024 Jan; 59(1):80-88. PubMed ID: 37968251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric ultrasound imaging for early-stage steatosis: Comparison with magnetic resonance imaging-based proton density fat fraction.
    Baek J; Basavarajappa L; Margolis R; Arthur L; Li J; Hoyt K; Parker KJ
    Med Phys; 2024 Feb; 51(2):1313-1325. PubMed ID: 37503961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
    Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
    J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MR assessment of liver fat, iron, and fibrosis: a concise overview of the liver "Triple Screen".
    Low G; Ferguson C; Locas S; Tu W; Manolea F; Sam M; Wilson MP
    Abdom Radiol (NY); 2023 Jun; 48(6):2060-2073. PubMed ID: 37041393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease.
    Jayaswal ANA; Levick C; Selvaraj EA; Dennis A; Booth JC; Collier J; Cobbold J; Tunnicliffe EM; Kelly M; Barnes E; Neubauer S; Banerjee R; Pavlides M
    Liver Int; 2020 Dec; 40(12):3071-3082. PubMed ID: 32730664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Fibrosis Staging with MR Elastography: Comparison of Diagnostic Performance between Patients with Chronic Hepatitis B and Those with Other Etiologic Causes.
    Chang W; Lee JM; Yoon JH; Han JK; Choi BI; Yoon JH; Lee KB; Lee KW; Yi NJ; Suh KS
    Radiology; 2016 Jul; 280(1):88-97. PubMed ID: 26844364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.
    Pavlides M; Banerjee R; Sellwood J; Kelly CJ; Robson MD; Booth JC; Collier J; Neubauer S; Barnes E
    J Hepatol; 2016 Feb; 64(2):308-315. PubMed ID: 26471505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-derived proton density fat fraction.
    Yoshizawa E; Yamada A
    J Med Ultrason (2001); 2021 Oct; 48(4):497-506. PubMed ID: 34669068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
    Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R
    J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis.
    Dennis A; Kelly MD; Fernandes C; Mouchti S; Fallowfield JA; Hirschfield G; Pavlides M; Harrison S; Chakravarthy MV; Banerjee R; Sanyal A
    Front Endocrinol (Lausanne); 2020; 11():575843. PubMed ID: 33584535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinoma.
    Liang LY; Wong VW; Tse YK; Yip TC; Lui GC; Chan HL; Wong GL
    Aliment Pharmacol Ther; 2019 Jun; 49(12):1509-1517. PubMed ID: 31025388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy.
    Seo YS; Kim MN; Kim SU; Kim SG; Um SH; Han KH; Kim YS
    Medicine (Baltimore); 2016 Mar; 95(12):e2985. PubMed ID: 27015173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Zhang T; Zhang G; Deng X; Zeng J; Jin J; Zeping H; Wu M; Zheng R
    Radiology; 2021 Nov; 301(2):350-359. PubMed ID: 34427463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease.
    Schaapman JJ; Tushuizen ME; Coenraad MJ; Lamb HJ
    J Magn Reson Imaging; 2021 Jun; 53(6):1623-1631. PubMed ID: 32822095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.